Impact of histological subtype on survival of patients with surgically-treated stage IA2-IIB cervical cancer: Adenocarcinoma versus squamous cell carcinoma

Gynecologic Oncology

Volumn 127, Issue 1, 2012, Pages 114-120

  Mabuchi, Seiji ^a   Okazawa, Mika ^b   Matsuo, Koji ^c   Kawano, Mahiru ^a   Suzuki, Osamu ^b   Miyatake, Takashi ^b   Enomoto, Takayuki ^a   Kamiura, Shoji ^b   Ogawa, Kazuhiko ^a   Kimura, Tadashi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Adenocarcinoma; Cervical cancer; Radical hysterectomy; Squamous cell carcinoma; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SPECIFIC SURVIVAL; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIOTHERAPY; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84865693926     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.06.021     Document Type: Article

References (29)

1. S.S. Wang, M.E. Sherman, A. Hildesheim, J.V. Lacey Jr., and S. Devesa Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000 Cancer 100 2004 1035 1044
2. K.E. Kjörstad Adenocarcinoma of the uterine cervix Gynecol Oncol 5 1977 219 223
3. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology, Cervical Cancer - v.1 www.nccn.org/professionals/physician-gls/f- guidelines.asp 2006
4. K. Katanyoo, S. Sanguanrungsirikul, and S. Manusirivithaya Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma in locally advanced cervical cancer Gynecol Oncol 125 2012 292 296
5. T. Nakanishi, H. Ishikawa, Y. Suzuki, T. Inoue, S. Nakamura, and K. Kuzuya A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix Gynecol Oncol 79 2000 289 293
6. Y.Y. Lee, C.H. Choi, and T.J. Kim A comparison of pure adenocarcinoma and squamous cell carcinoma of the cervix after radical hysterectomy in stage IB-IIA Gynecol Oncol 120 2011 439 443
7. J.Y. Park, D.Y. Kim, J.H. Kim, Y.M. Kim, Y.T. Kim, and J.H. Nam Outcomes after radical hysterectomy in patients with early-stage adenocarcinoma of uterine cervix Br J Cancer 102 2010 1692 1698
8. M.P. Hopkins, and G.W. Morley A comparison of adenocarcinoma and squamous cell carcinoma of the cervix Obstet Gynecol 77 1991 912 917
9. J.S. Berek, N.F. Hacker, Y.S. Fu, J.R. Sokale, R.C. Leuchter, and L.D. Lagasse Adenocarcinoma of the uterine cervix: histologic variables associated with lymph node metastasis and survival Obstet Gynecol 65 1985 46 52
10. W. Kleine, K. Rau, D. Schwoeorer, and A. Pfleiderer Prognosis of the adenocarcinoma of the cervix uteri: a comparative study Gynecol Oncol 35 1989 145 149
11. R.J. Chen, Y.H. Lin, C.A. Chen, S.C. Huang, S.N. Chow, and C.Y. Hsieh Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan Gynecol Oncol 73 1999 184 190
12. T. Irie, J. Kigawa, and Y. Minagawa Prognosis and clinicopathological characteristics of Ib-IIb adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy Eur J Surg Oncol 26 2000 464 467
13. K.Y. Look, V.L. Brunetto, and D.L. Clarke-Pearson An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study Gynecol Oncol 63 1996 304 311
14. A. Ayhan, R.A. Al, C. Baykal, E. Demirtas, K. Yüce, and A. Ayhan A comparison of prognoses of FIGO stage IB adenocarcinoma and squamous cell carcinoma Int J Gynecol Cancer 14 2004 279 285
15. D. Grisaru, A. Covens, and B. Chapman Does histology influence prognosis in patients with early-stage cervical carcinoma? Cancer 92 Dec 15 2001 2999 3004
16. T. Kasamatsu, T. Onda, and M. Sawada Radical hysterectomy for FIGO stage I-IIB adenocarcinoma of the uterine cervix Br J Cancer 100 2009 1400 1405
17. K.B. Lee, J.M. Lee, C.Y. Park, K.B. Lee, H.Y. Cho, and S.Y. Ha What is the difference between squamous cell carcinoma and adenocarcinoma of the cervix? A matched case-control study Int J Gynecol Cancer 16 2006 1569 1573
18. H.M. Shingleton, M.C. Bell, and A. Fremgen Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix? Cancer 76 1995 1948 1955
19. WHO F.A. Tavassoli, M.R. Stratton, WHO classification of tumours: pathology and genetics of tumours of the breast and female genital organs Chapter 5: Tumours of the Uterine Cervix 2002 IARC Press Lyon 259 289
20. S. Mabuchi, K. Morishige, and F. Isohashi Postoperative concurrent nedaplatin-based chemoradiotherapy improves survival in early-stage cervical cancer patients with adverse risk factors Gynecol Oncol 115 2009 482 487
21. S. Mabuchi, M. Okazawa, and F. Isohashi Postoperative whole pelvic radiotherapy plus concurrent chemotherapy versus extended-field irradiation for early-stage cervical cancer patients with multiple pelvic lymph node metastases Gynecol Oncol 120 2011 94 100
22. S. Mabuchi, M. Okazawa, and F. Isohashi Radical hysterectomy with adjuvant radiotherapy versus definitive radiotherapy alone for FIGO stage IIB cervical cancer Gynecol Oncol 123 2011 241 247
23. M. Okazawa, S. Mabuchi, and F. Isohashi The prognostic significance of multiple pelvic node metastases in cervical cancer patients treated with radical hysterectomy plus adjuvant chemoradiotherapy Int J Gynecol Cancer 22 2012 490 497
24. S. Mabuchi, and T. Kimura Nedaplatin: a radiosensitizing agent for patients with cervical cancer Chemother Res Pract 2011 2011 963159
25. S. Mabuchi, F. Isohashi, and Y. Yoshioka Prognostic factors for survival in patients with recurrent cervical cancer previously treated with radiotherapy Int J Gynecol Cancer 20 2010 834 840
26. S. Mabuchi, F. Isohashi, and S. Maruoka Post-treatment follow-up procedures in cervical cancer patients previously treated with radiotherapy Arch Gynecol Obstet 286 2012 179 185
27. W.A. Peters III, P.Y. Liu, R.J. Barrett II, R.J. Stock, B.J. Monk, and J.S. Berek Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J Clin Oncol 18 2000 1606 1613
28. J. Kodama, N. Seki, and S. Masahiro Prognostic factors in stage IB-IIB cervical adenocarcinoma patients treated with radical hysterectomy and pelvic lymphadenectomy J Surg Oncol 101 2010 413 417
29. H.C. Kitchener, W. Hoskins, W. Small Jr., G.M. Thomas, and E.L. Trimble The development of priority cervical cancer trials: a Gynecologic Cancer InterGroup report Int J Gynecol Cancer 20 2010 1092 1100